Contact our key representative
Submitted
Thank you for getting in touch.
We will get back in touch with you soon!
Have a great day!
Dexcom is a global medical device company completed the delivery of its new European headquarters and advanced manufacturing facility in Ireland, supporting the expansion of high‑volume production of continuous glucose monitoring (CGM) devices. The development represents a significant strategic investment in regulated life sciences manufacturing.
The project comprised approximately 30,000 m² of floor space, including 4,200 m² of ISO‑certified cleanroom accommodation, with capacity to manufacture up to 60 million CGM units per year. The facility was delivered through a phased completion strategy, enabling production equipment to be installed and commissioned in late 2025, followed by full completion in early 2026. The programme was delivered on schedule and within budget.
Linesight provided Project Management and Cost Management services, supporting disciplined delivery and commercial certainty across this complex programme.
The project was delivered against a tightly constrained programme, with immovable milestones linked directly to production readiness in a regulated manufacturing environment. Maintaining control over scope, cost, and quality was critical throughout delivery.
A strong no‑change culture was established early in the programme and enforced rigorously to protect schedule and budget certainty. Quality assurance was embedded through monthly quality reviews, supporting compliance with cleanroom and regulatory requirements.
As the project approached handover, Linesight increased on‑site presence, implementing daily walk‑throughs during commissioning and snagging. This enabled issues to be resolved in real time and supported a smooth transition into live manufacturing operations.
The wider project team operated within a digitally enabled delivery environment, with design coordination managed through BIM 360, supporting collaboration and efficient issue resolution across disciplines.
The project was recognised at the Engineering Excellence Awards 2026, where it won Large Civil Project of the Year, reflecting excellence in delivery on a complex life sciences programme.